Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Landau

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL AmyloidosisHeather Landau, Oscar Lahoud, Sean Devlin, et al.
Leukemia & Lymphoma|January 21, 2020
A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium studyHani Hassoun, Ruthee Bayer, Sean Devlin, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2020
Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant RecipientsChakra P Chaulagain, Julia M Diacovo, Leah Elson, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosisSuzanne Lentzsch, Galina G Lagos, Raymond L Comenzo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 3, 2025
Frontline Dara-CyBorD for AL amyloidosis: high response rates and cytogenetic insights from a real-world cohortXia Wu, Eugène Brailovski, Denis Toskic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain AmyloidosisVina P Nguyen, Heather Landau, Karen Quillen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II StudySuzanne Lentzsch, Galina G Lagos, Raymond L Comenzo, et al.
Leukemia & Lymphoma|January 14, 2016
Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantationHeather Landau, Kevin Wood, David J Chung, et al.
Journal of the American Society for Mass Spectrometry|June 20, 2020
Jettison-MS of Nucleic Acid SpeciesPoguang Wang, Gunjan L Shah, Heather Landau, et al.
JACC. Cardiooncology|October 29, 2020
Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL AmyloidosisKatherine Lee Chuy, Esther Drill, Ji Can Yang, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL AmyloidosisHeather Landau, Oscar Lahoud, Sean Devlin, et al.
Leukemia & Lymphoma|January 21, 2020
A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium studyHani Hassoun, Ruthee Bayer, Sean Devlin, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2020
Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant RecipientsChakra P Chaulagain, Julia M Diacovo, Leah Elson, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosisSuzanne Lentzsch, Galina G Lagos, Raymond L Comenzo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 3, 2025
Frontline Dara-CyBorD for AL amyloidosis: high response rates and cytogenetic insights from a real-world cohortXia Wu, Eugène Brailovski, Denis Toskic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain AmyloidosisVina P Nguyen, Heather Landau, Karen Quillen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II StudySuzanne Lentzsch, Galina G Lagos, Raymond L Comenzo, et al.
Leukemia & Lymphoma|January 14, 2016
Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantationHeather Landau, Kevin Wood, David J Chung, et al.
Journal of the American Society for Mass Spectrometry|June 20, 2020
Jettison-MS of Nucleic Acid SpeciesPoguang Wang, Gunjan L Shah, Heather Landau, et al.
JACC. Cardiooncology|October 29, 2020
Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL AmyloidosisKatherine Lee Chuy, Esther Drill, Ji Can Yang, et al.
Pageof 10